OXiGENE To Present At The SG Cowen & Co., LLC 26th Annual Health Care Conference

WALTHAM, Mass.--(BUSINESS WIRE)--March 2, 2006--OXiGENE, Inc. (NASDAQ: OXGN, XSSE: OXGN), a leading developer of biopharmaceutical compounds to treat cancer and certain ophthalmologic diseases, announced today that it has been selected to present at the Cowen & Co. 26th Annual Health Care Conference in Boston, Massachusetts. Frederick Driscoll, OXiGENE's President and Chief Executive Officer, will present on Tuesday, March 7, 2006, at the Boston Marriott Hotel at 1:30 p.m. EST.
MORE ON THIS TOPIC